🎉 Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application

VANCOUVER, BC, March 2, 2021 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in developing technology to advance psychedelic-related treatments, is pleased to announce the completion of its initial strategic equity investment of equal to approximately 13% ownership in ATMA Journey Centers Inc. (“ATMA”) in accordance with the terms of the letter of intent (the “LOI”) announced on January 12, 2021.

MINDCURE’s initial strategic investment of $500,000 will strengthen our relationship with Calgary-based private healthcare company, ATMA, which has recently provided psychedelic-assisted therapy sessions using psilocybin for patients with section 56 exemptions.1 MINDCURE will leverage the growing partnership with ATMA to secure a network of clinics in which to deploy and test MINDCURE’s iSTRYM platform, and concurrently,  provide MINDCURE with access to patient data accelerating the growth of iSTRYM‘s database. This will lead to better diagnoses, treatments and personalized care.

“Our partnership with ATMA represents a huge step forward for healing today in Canada and around the world. By accelerating the development of our research and technology platform, iSTRYM, we’re closer to minimizing the gaps that exist in health care, all the way from research to the deployment of care. It’s an amazing opportunity to innovate with pioneers of the psychedelic therapy industry by creating proprietary research, identifying commonalities, and driving real transformative results for individuals using psychedelic medicines,” said Kelsey Ramsden, President & CEO, MINDCURE.

Access to ATMA’s patient data will contribute to MINDCURE’s proprietary technology, iSTRYM, ultimately helping to optimize treatment for ATMA’s patients and providing a rich data resource for MINDCURE, in accordance with the LOI.

“As the first commercial company in Canada to announce legally treating a palliative patient with psychedelic-assisted therapy using psilocybin, we’re optimistic about the progression to better care options for Canadians. By partnering with MINDCURE, we’re enforcing consistency in terms of protocols, as well as the ability to automate patterns in our patients’ conditions. Overall, this will lead to better patient care, and a stronger foundation for this innovative and leading-edge industry,” said Greg Habstritt, President of ATMA Journey Centers Inc. “Our mission is to deliver effective and innovative healing and transformative experiences that leverage the compelling science around psychedelics. We’re committed to providing the resources, safeguards, expertise, and accessibility into insights that our work uncovers, in order to advocate for better care and new treatment options.”

1 “Exemptions,” The Government of Canada (Health Canada, November 13, 2020), https://www.canada.ca/en/health-canada/services/health-concerns/controlled-substances-precursor-chemicals/exemptions.html

More News and Media:

Colorado River frog source of 5-MeO-DMT

What is 5-MeO-DMT?

What is 5-MeO-DMT? If you haven’t heard of 5-MeO-DMT, you’re not alone. The use of 5-MeO-DMT as a clinical and therapeutic medicine is relatively new and there are, so far,

What is Ketamine used for?

What is Ketamine-Assisted Therapy?

Ketamine has been used in medical settings and is now getting more support for use in therapy applications. Here’s what you need to know about ketamine-assisted therapy. What is Ketamine?

Female therapist smiling

Traditional Therapy vs. Psychedelic Therapy

With interest in psychedelic therapy increasing from potential practitioners and patients, there has been an increase in questions about psychedelic therapy. We’re here to help answer some of those burning

What is Ayahuasca-Assisted Therapy?

Ayahuasca has been used in healing sessions for thousands of years and is now making it’s way into western medicine and therapy settings. Here’s what you need to know about

What is Psilocybin-Assisted Therapy?

Psychedelic-assisted therapy is slowly becoming a legal therapy option across the US and Canada, with psilocybin-assisted therapy leading the way. But what is psilocybin and how is it used in